Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.37 is 76% below its 5-year average of 9.90, near the low end of its 5-year range (2.37–23.15).
As of the fiscal period ended Tuesday, June 30, 2026. 46.75% below its 12-month average of 4.45.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.37.
QUICK RATIO (ACID-TEST)
2.37
QUICK RATIO (ACID-TEST) AVG TTM
4.45
QUICK RATIO (ACID-TEST) AVG 3Y
7.28
QUICK RATIO (ACID-TEST) AVG 5Y
9.90
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-46.75%
CURRENT VS 3Y AVG
-67.45%
CURRENT VS 5Y AVG
-76.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-29.27%
vs the sector median at left
Connect Biopharma Holdings Limited
Market Cap
$57.18M
Quick Ratio (Acid-Test)
2.37
TTM Avg
4.45
3Y Avg
7.28
5Y Avg
9.90
Market Cap
$57.87M
Quick Ratio (Acid-Test)
4.29
TTM Avg
4.53
3Y Avg
3.33
5Y Avg
3.09
Market Cap
$57.88M
Quick Ratio (Acid-Test)
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
Market Cap
$57.98M
Quick Ratio (Acid-Test)
9.48
TTM Avg
13.86
3Y Avg
12.45
5Y Avg
13.81
Market Cap
$58.85M
Quick Ratio (Acid-Test)
4.25
TTM Avg
2.40
3Y Avg
3.43
5Y Avg
5.08
Market Cap
$58.54M
Quick Ratio (Acid-Test)
1.23
TTM Avg
0.89
3Y Avg
0.93
5Y Avg
1.06
Market Cap
$59.03M
Quick Ratio (Acid-Test)
6.71
TTM Avg
8.38
3Y Avg
9.61
5Y Avg
10.03
Market Cap
$56.02M
Quick Ratio (Acid-Test)
2.43
TTM Avg
1.42
3Y Avg
0.93
5Y Avg
1.83
Market Cap
$60.42M
Quick Ratio (Acid-Test)
3.15
TTM Avg
4.21
3Y Avg
4.66
5Y Avg
4.26
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $57.18M | 2.37 | 4.45 | 7.28 | 9.90 |
| Talphera, Inc. (TLPH)vs › | $57.87M | 4.29 | 4.53 | 3.33 | 3.09 |
| PDS Biotechnology Corporation (PDSB)vs › | $57.88M | 0.57 | 2.81 | 4.44 | 7.47 |
| Boundless Bio, Inc. (BOLD)vs › | $57.98M | 9.48 | 13.86 | 12.45 | 13.81 |
| Xilio Therapeutics, Inc. (XLO)vs › | $58.85M | 4.25 | 2.40 | 3.43 | 5.08 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.54M | 1.23 | 0.89 | 0.93 | 1.06 |
| Adicet Bio, Inc. (ACET)vs › | $59.03M | 6.71 | 8.38 | 9.61 | 10.03 |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | 2.43 | 1.42 | 0.93 | 1.83 |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | 3.15 | 4.21 | 4.66 | 4.26 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.05M | 1.35 | 1.97 | 5.50 | 8.52 |
Quick Ratio
2.37
Excludes inventory
Current Ratio
2.37
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.37 |
| 2025-12-31 | 3.74 |
| 2025-06-30 | 7.24 |
| 2024-12-31 | 11.46 |
| 2024-06-30 | 12.04 |
| 2023-12-31 | 4.85 |
| 2023-06-30 | 9.26 |
| 2022-12-31 | 9.97 |
| 2022-06-30 | 9.58 |
| 2021-12-31 | 15.30 |
| 2021-06-30 | 23.15 |
| 2020-12-31 | 27.81 |
| 2020-06-30 | 0.00 |
| 2019-12-31 | 12.44 |
| 2019-06-30 | 23.79 |
| 2018-12-31 | 70.44 |
